The current CE-mark applies to the professional use of the test platform Egoo.Health for sale on the European market.
Corona virus, COVID-19, has limited impact on Qlife Holding AB
Qlife went public on March 2 with a clear strategy for the next year, that strategy is still being followed and we do not see any large obstacles to it due to the Corona virus outbreak. The interest for our Egoo Home System has not waned. On the contrary, the interest in being able to test patients at home compared to at a hospital is increasingly attractive in a time where limitation of infection is in focus. This is a focus that will have even more attention in the future when our health sector needs to be prepared if or when a similar situation evolves.
This increasing interest makes up for the short-term effects of the corona virus where Qlife are following the guidelines of the Danish government to limit the spread and to protect their employees from infection. All non-essential international travels have been cancelled and all employees, for whom its possible, are from today, March 13th working from home.
“We believe that the potential for the Egoo Home System is increasing in the long run, and we prepare ourselves for deliveries to a healthcare system that will have been under a lot of pressure and will need all the technological aid they can to bounce back stronger than before” Thomas Warthoe, CEO
Qlife expects to CE mark its COVID-19 test for professional use in the Egoo.Health system within short.
Since May 2020, Qlife has been handling all testing for COVID-19 for professional football in Denmark.
On November 13, Qlife was informed that the Danish Medicines Agency (Lægemiddelstyrelsen) had rejected the application for temporay approval in Denmark “in the interest of health protection” for th
”We will do our utmost to protect the participating players against the coronavirus”, says Frank Smith, Covid-19 Officer, European Handball Federation Euro 2020 “It requires testing with high preci
Resolution on (A) employee option program; and (B) directed issue of warrants and approval of transfer of warrants
FINANCIAL SUMMARY - THIRD QUARTER 2020
In parallel to the ongoing process of preparing and putting together the dossier for the CE-mark, Qlife has submitted an application for placing the product on the market at this stage, as it offer
The Nomination Committee consists of the following persons, who together represent approximately 39 percent of the company's shares and votes.